Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group.
Borowitz
M J
MJ
Duke University Medical Center, Durham, NC 27710.
Carroll
A J
AJ
Shuster
J J
JJ
Look
A T
AT
Behm
F G
FG
Pullen
D J
DJ
Land
V J
VJ
Steuber
P
P
Crist
W M
WM
D015703:Antigens, CD / Q000032:analysis; D002648:Child; D006801:Humans; D016130:Immunophenotyping; D011003:Ploidies; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000276:immunology / Q000401:mortality*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000276:immunology / Q000401:mortality*; D011379:Prognosis; D015996:Survival Rate
D015703:Antigens, CD